BioCAST/IFCT-1002: epidemiological and molecular features of lung cancer in never-smokers

Couraud Sébastien, Souquet Pierre-Jean, Paris Christophe, Dô Pascal, Doubre Hélène, Pichon Eric, Dixmier Adrien, Monnet Isabelle, Etienne-Mastroianni Bénédicte, Vincent Michel, Trédaniel Jean, Perrichon Marielle, Foucher Pascal, Coudert Bruno, Moro-Sibilot Denis, Dansin Eric, Labonne Stéphanie, Missy Pascale, Morin Franck, Blanché Hélène, Zalcman Gérard

Source: Eur Respir J 2015; 45: 1403-1414
Journal Issue: May
Disease area: Thoracic oncology

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Couraud Sébastien, Souquet Pierre-Jean, Paris Christophe, Dô Pascal, Doubre Hélène, Pichon Eric, Dixmier Adrien, Monnet Isabelle, Etienne-Mastroianni Bénédicte, Vincent Michel, Trédaniel Jean, Perrichon Marielle, Foucher Pascal, Coudert Bruno, Moro-Sibilot Denis, Dansin Eric, Labonne Stéphanie, Missy Pascale, Morin Franck, Blanché Hélène, Zalcman Gérard. BioCAST/IFCT-1002: epidemiological and molecular features of lung cancer in never-smokers. Eur Respir J 2015; 45: 1403-1414

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Molecular epidemiology in non small cell lung cancer (NSCLC) tumors: implication of gender and histological features
Source: Eur Respir J 2006; 28: Suppl. 50, 335s
Year: 2006

Multi-omic molecular profiling of lung cancer in COPD
Source: Eur Respir J, 52 (1) 1702665; 10.1183/13993003.02665-2017
Year: 2018



Comparison of demographic, clinico-pathological and survival profile of lung cancer in smokers and non-smokers
Source: Annual Congress 2009 - Clinical aspects and epidemiology in lung cancer
Year: 2009

Primary lung cancer in never smokers: clinicopathological analysis of 46 cases
Source: Eur Respir J 2005; 26: Suppl. 49, 493s
Year: 2005

New findings in the molecular biology of lung cancer: clinical application
Source: European Multidisciplinary Conference in Thoracic Oncology 2009
Year: 2009

Cytological diagnostics of lung cancer: our experience
Source: Eur Respir J 2005; 26: Suppl. 49, 306s
Year: 2005

Comparative characteristics of lung cancer in smokers and nonsmokers
Source: Eur Respir J 2001; 18: Suppl. 33, 115s
Year: 2001

Prevalence and clinical characteristics of lung cancer with COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 321s
Year: 2005

Latest treatable molecular alterations in lung cancer
Source: International Congress 2017 – A novel approach to lung cancer
Year: 2017


Pathology and molecular biology of lung cancer
Source: Annual Congress 2006 - PG19 - Thoracic oncology: diagnostic assessment of lung cancer
Year: 2006



Role of biomarkers for early detection of lung cancer and chemoprevention
Source: Eur Respir J 2002; 19: 1151-1158
Year: 2002



The Liverpool Lung Project: a molecular epidemiological study of early lung cancer detection
Source: Eur Respir J 2002; 20: 464-479
Year: 2002



Lung cancer screening in never-smokers: facts and remaining issues
Source: Eur Respir J, 56 (5) 2002949; 10.1183/13993003.02949-2020
Year: 2020



Small cell lung cancer in never-smokers
Source: Eur Respir J 2016; 47: 947-953
Year: 2016



A clinical study of lung cancer cases with underlying COPD in relation to the COPD phenotype
Source: Annual Congress 2010 - Regulation of airway hyperresponsiveness and bronchodilators
Year: 2010


Differences in epidemiological and clinical features in non-small cell lung cancer (NSCLC) in never and ever smokers
Source: International Congress 2015 – Diagnosis and therapy of lung cancer
Year: 2015


COPD and lung cancer incidence in never smokers
Source: International Congress 2019 – Asthma and COPD comorbidities
Year: 2019